{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:48:23Z","timestamp":1794833303997,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antibiotic-induced microbiome depletion (AIMD) has been used frequently to study the role of the gut microbiome in pathological conditions. However, unlike germ-free mice, the effects of AIMD on host metabolism remain incompletely understood. Here we show the effects of AIMD to elucidate its effects on gut homeostasis, luminal signaling, and metabolism. We demonstrate that AIMD, which decreases luminal Firmicutes and Bacteroidetes species, decreases baseline serum glucose levels, reduces glucose surge in a tolerance test, and improves insulin sensitivity without altering adiposity. These changes occur in the setting of decreased luminal short-chain fatty acids (SCFAs), especially butyrate, and the secondary bile acid pool, which affects whole-body bile acid metabolism. In mice, AIMD alters cecal gene expression and gut glucagon-like peptide 1 signaling. Extensive tissue remodeling and decreased availability of SCFAs shift colonocyte metabolism toward glucose utilization. We suggest that AIMD alters glucose homeostasis by potentially shifting colonocyte energy utilization from SCFAs to glucose.<\/jats:p>","DOI":"10.1038\/s41467-018-05336-9","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T12:17:37Z","timestamp":1531743457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":534,"title":["Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-5982","authenticated-orcid":false,"given":"Amir","family":"Zarrinpar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7007-197X","authenticated-orcid":false,"given":"Amandine","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjiang Z.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-489X","authenticated-orcid":false,"given":"Max W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse A.","family":"Marotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Saghatelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satchidananda","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"5336_CR1","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480 e1412 (2016).","journal-title":"Cell"},{"key":"5336_CR2","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1172\/JCI79214","volume":"125","author":"TC Shen","year":"2015","unstructured":"Shen, T. C. et al. Engineering the gut microbiota to treat hyperammonemia. J. Clin. Invest. 125, 2841\u20132850 (2015).","journal-title":"J. Clin. Invest."},{"key":"5336_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2004.07.002","volume":"118","author":"S Rakoff-Nahoum","year":"2004","unstructured":"Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229\u2013241 (2004).","journal-title":"Cell"},{"key":"5336_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.chom.2013.09.012","volume":"14","author":"A Wichmann","year":"2013","unstructured":"Wichmann, A. et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14, 582\u2013590 (2013).","journal-title":"Cell Host Microbe"},{"key":"5336_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1073\/pnas.0605374104","volume":"104","author":"F Backhed","year":"2007","unstructured":"Backhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979\u2013984 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5336_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"5336_CR7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1136\/gutjnl-2014-308820","volume":"64","author":"A Morgun","year":"2015","unstructured":"Morgun, A. et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 64, 1732\u20131743 (2015).","journal-title":"Gut"},{"key":"5336_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0297-9","volume":"8","author":"D Mahana","year":"2016","unstructured":"Mahana, D. et al. Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet. Genome Med. 8, 48 (2016).","journal-title":"Genome Med."},{"key":"5336_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","volume":"488","author":"I Cho","year":"2012","unstructured":"Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621\u2013626 (2012).","journal-title":"Nature"},{"key":"5336_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705\u2013721 (2014).","journal-title":"Cell"},{"key":"5336_CR11","doi-asserted-by":"crossref","unstructured":"Canfora, E. E., Jocken, J. W. & Blaak E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 10, 577-591 (2015).","DOI":"10.1038\/nrendo.2015.128"},{"key":"5336_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99\u2013103 (2013).","journal-title":"Nature"},{"key":"5336_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55\u201360 (2012).","journal-title":"Nature"},{"key":"5336_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509\u20131517 (2009).","journal-title":"Diabetes"},{"key":"5336_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913\u2013916 e917 (2012).","journal-title":"Gastroenterology"},{"key":"5336_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/apt.12084","volume":"36","author":"A Zarrinpar","year":"2012","unstructured":"Zarrinpar, A. & Loomba, R. Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 36, 909\u2013921 (2012).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"5336_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4, 2384 (2013).","journal-title":"Nat. Commun."},{"key":"5336_CR18","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jhep.2013.11.034","volume":"60","author":"A Vrieze","year":"2014","unstructured":"Vrieze, A. et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 60, 824\u2013831 (2014).","journal-title":"J. Hepatol."},{"key":"5336_CR19","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1007\/s00125-012-2648-4","volume":"55","author":"BM Carvalho","year":"2012","unstructured":"Carvalho, B. M. et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55, 2823\u20132834 (2012).","journal-title":"Diabetologia"},{"key":"5336_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000146256","volume":"62","author":"CJ Chou","year":"2008","unstructured":"Chou, C. J., Membrez, M. & Blancher, F. Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice. Nestle Nutr. Workshop Ser. Pediatr. Program 62, 127\u2013137 (2008). discussion 137\u2013140.","journal-title":"Nestle Nutr. Workshop Ser. Pediatr. Program"},{"key":"5336_CR21","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1096\/fj.14-265983","volume":"29","author":"I Hwang","year":"2015","unstructured":"Hwang, I. et al. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 29, 2397\u20132411 (2015).","journal-title":"FASEB J."},{"key":"5336_CR22","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/nm.3994","volume":"21","author":"N Suarez-Zamorano","year":"2015","unstructured":"Suarez-Zamorano, N. et al. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat. Med. 21, 1497\u20131501 (2015).","journal-title":"Nat. Med."},{"key":"5336_CR23","doi-asserted-by":"publisher","first-page":"e17996","DOI":"10.1371\/journal.pone.0017996","volume":"6","author":"DH Reikvam","year":"2011","unstructured":"Reikvam, D. H. et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS ONE 6, e17996 (2011).","journal-title":"PLoS ONE"},{"key":"5336_CR24","first-page":"27663","volume":"26","author":"S Mandal","year":"2015","unstructured":"Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663 (2015).","journal-title":"Microb. Ecol. Health Dis."},{"key":"5336_CR25","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1128\/AEM.71.12.8228-8235.2005","volume":"71","author":"C Lozupone","year":"2005","unstructured":"Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228\u20138235 (2005).","journal-title":"Appl. Environ. Microbiol."},{"key":"5336_CR26","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814\u2013821 (2013).","journal-title":"Nat. Biotechnol."},{"key":"5336_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer, J. et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 15, 423\u2013430 (2014).","journal-title":"Nat. Immunol."},{"key":"5336_CR28","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.3389\/fmicb.2017.02306","volume":"8","author":"RR Rodrigues","year":"2017","unstructured":"Rodrigues, R. R. et al. Antibiotic-induced alterations in gut microbiota are associated with changes in glucose metabolism in healthy mice. Front. Microbiol. 8, 2306 (2017).","journal-title":"Front. Microbiol."},{"key":"5336_CR29","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1210\/en.2004-0015","volume":"145","author":"PL Brubaker","year":"2004","unstructured":"Brubaker, P. L. & Drucker, D. J. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145, 2653\u20132659 (2004).","journal-title":"Endocrinology"},{"key":"5336_CR30","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2011-301955","volume":"62","author":"S El Aidy","year":"2013","unstructured":"El Aidy, S. et al. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut 62, 1306\u20131314 (2013).","journal-title":"Gut"},{"key":"5336_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000051874","volume":"63","author":"MM Byrne","year":"2001","unstructured":"Byrne, M. M. et al. Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma. Digestion 63, 61\u201368 (2001).","journal-title":"Digestion"},{"key":"5336_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","volume":"23","author":"K Martinez-Guryn","year":"2018","unstructured":"Martinez-Guryn, K. et al. Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids. Cell Host Microbe 23, 458\u2013469 e455 (2018).","journal-title":"Cell Host Microbe"},{"key":"5336_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2014.09.010","volume":"64","author":"H Munzberg","year":"2015","unstructured":"Munzberg, H. & Morrison, C. D. Structure, production and signaling of leptin. Metabolism 64, 13\u201323 (2015).","journal-title":"Metabolism"},{"key":"5336_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3945\/jn.114.206029","volume":"145","author":"CC Ronveaux","year":"2015","unstructured":"Ronveaux, C. C., Tome, D. & Raybould, H. E. Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling. J. Nutr. 145, 672\u2013680 (2015).","journal-title":"J. Nutr."},{"key":"5336_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2337\/diabetes.52.2.252","volume":"52","author":"Y Anini","year":"2003","unstructured":"Anini, Y. & Brubaker, P. L. Role of leptin in the regulation of glucagon-like peptide 1 secretion. Diabetes 52, 252\u2013259 (2003).","journal-title":"Diabetes"},{"key":"5336_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Chavez-Talavera","year":"2017","unstructured":"Chavez-Talavera, O., Tailleux, A., Lefebvre, P. & Staels, B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology 152, 1679\u20131694 e1673 (2017).","journal-title":"Gastroenterology"},{"key":"5336_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/pathogens3010014","volume":"3","author":"P Gerard","year":"2013","unstructured":"Gerard, P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3, 14\u201324 (2013).","journal-title":"Pathogens"},{"key":"5336_CR38","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"},{"key":"5336_CR39","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1053\/j.gastro.2014.02.008","volume":"146","author":"M Nieuwdorp","year":"2014","unstructured":"Nieuwdorp, M., Gilijamse, P. W., Pai, N. & Kaplan, L. M. Role of the microbiome in energy regulation and metabolism. Gastroenterology 146, 1525\u20131533 (2014).","journal-title":"Gastroenterology"},{"key":"5336_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"E Le Chatelier","year":"2013","unstructured":"Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541\u2013546 (2013).","journal-title":"Nature"},{"key":"5336_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cmet.2016.06.016","volume":"24","author":"D Reijnders","year":"2016","unstructured":"Reijnders, D. et al. Effects of gut microbiota manipulation by antibiotics on host metabolism in obese humans: a randomized double-blind placebo-controlled trial. Cell Metab. 24, 63\u201374 (2016).","journal-title":"Cell Metab."},{"key":"5336_CR42","doi-asserted-by":"crossref","unstructured":"Mikkelsen, K. H., Allin, K. H. & Knop, F. K. Effect of antibiotics on gut microbiota, glucose metabolism and bodyweight regulation\u2014a review of the literature. Diabetes Obes. Metab.\n                           18, 444-53 (2016).","DOI":"10.1111\/dom.12637"},{"key":"5336_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cmet.2014.11.008","volume":"20","author":"A Zarrinpar","year":"2014","unstructured":"Zarrinpar, A., Chaix, A., Yooseph, S. & Panda, S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab. 20, 1006\u20131017 (2014).","journal-title":"Cell Metab."},{"key":"5336_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tem.2015.11.007","volume":"27","author":"A Zarrinpar","year":"2016","unstructured":"Zarrinpar, A., Chaix, A. & Panda, S. Daily eating patterns and their impact on health and disease. Trends Endocrinol. Metab. 27, 69\u201383 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"5336_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aac6468","volume":"350","author":"AM Schieber","year":"2015","unstructured":"Schieber, A. M. et al. Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling. Science 350, 558\u2013563 (2015).","journal-title":"Science"},{"key":"5336_CR46","first-page":"15","volume-title":"Bioinformatics","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013)."},{"key":"5336_CR47","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"5336_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"5336_CR49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.cmet.2014.11.001","volume":"20","author":"A Chaix","year":"2014","unstructured":"Chaix, A., Zarrinpar, A., Miu, P. & Panda, S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 20, 991\u20131005 (2014).","journal-title":"Cell Metab."},{"key":"5336_CR50","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 41, e1 (2013).","journal-title":"Nucleic Acids Res."},{"key":"5336_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","volume":"15","author":"M Hatori","year":"2012","unstructured":"Hatori, M. et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 15, 848\u2013860 (2012).","journal-title":"Cell Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05336-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05336-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:06:52Z","timestamp":1671534412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05336-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5336"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05336-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"24 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2872"}}